Viral Inactivation Market
Viral Inactivation Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
Viral Inactivation Market Size and Growth
The Viral Inactivation market is experiencing robust growth, driven by increasing demand for safety in biopharmaceutical products. The global market size is projected to reach approximately $500 million by 2025, fueled by advancements in technology and heightened regulatory scrutiny. Key trends include innovation in methods and growing investments in research.
Companies Covered (Covid 19 Impact Covered)
◍ Danaher
◍ Merck
◍ Parker Hannifin
◍ Sartorius
◍ SGS
The viral inactivation market features key players like Danaher, Merck, and Sartorius, focusing on innovative technologies. These companies enhance safety in biopharmaceuticals, contributing to market growth.
Notable sales include Danaher at $22 billion and Merck at $12 billion, reflecting strong demand for viral inactivation solutions and compliance.
◍ Charles River Laboratories International
◍ Clean Cells
◍ Rad Source Technologies
◍ Texcell
◍ Viral Inactivated Plasma Systems
◍ Wuxi Pharmatech (Cayman)
Request Sample Report
Market Segmentation
By Application
◍ Blood and Blood Products
◍ Cellular and Gene Therapy Products
◍ Stem Cell Products
◍ Tissue and Tissue Products
◍ Vaccines and Therapeutics
By Product
◍ Kits and Reagents
◍ Services
◍ Viral Inactivation Systems and Accessories
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
